Pain Therapeutics Receives Complete Response Letter for Remoxy ER

AUSTIN, Texas, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) announced today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) on the resubmission of its new drug...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news